ZCWPW2
gene geneOn this page
Also known as ZCW2
Summary
ZCWPW2 (zinc finger CW-type and PWWP domain containing 2, HGNC:23574) is a protein-coding gene on chromosome 3p24.1, encoding Zinc finger CW-type PWWP domain protein 2 (Q504Y3). Histone methylation reader which binds to non-methylated (H3K4me0), monomethylated (H3K4me1), dimethylated (H3K4me2) and trimethylated (H3K4me3) ‘Lys-4’ on histone H3.
Enables methylated histone binding activity. Predicted to be active in nucleus.
Source: NCBI Gene 152098 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 77 total
- MANE Select transcript:
NM_001040432
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23574 |
| Approved symbol | ZCWPW2 |
| Name | zinc finger CW-type and PWWP domain containing 2 |
| Location | 3p24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZCW2 |
| Ensembl gene | ENSG00000206559 |
| Ensembl biotype | protein_coding |
| OMIM | 621188 |
| Entrez | 152098 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 protein_coding
ENST00000383768, ENST00000419130, ENST00000420223, ENST00000428875, ENST00000457897, ENST00000888968, ENST00000888969, ENST00000888970, ENST00000888971, ENST00000888972, ENST00000920408
RefSeq mRNA: 3 — MANE Select: NM_001040432
NM_001040432, NM_001324169, NM_001324170
CCDS: CCDS33723
Canonical transcript exons
ENST00000383768 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001336158 | 28348721 | 28349203 |
| ENSE00001498559 | 28520992 | 28521116 |
| ENSE00001498560 | 28515554 | 28515621 |
| ENSE00001498561 | 28514064 | 28514122 |
| ENSE00001498562 | 28492127 | 28492173 |
| ENSE00001498563 | 28478814 | 28478931 |
| ENSE00001498564 | 28435110 | 28435269 |
| ENSE00001498565 | 28413056 | 28413400 |
| ENSE00001498566 | 28390498 | 28390617 |
| ENSE00003841787 | 28524527 | 28526358 |
Expression profiles
Bgee: expression breadth ubiquitous, 163 present calls, max score 86.31.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.7845 / max 208.2473, expressed in 1219 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 35786 | 2.8761 | 858 |
| 202711 | 0.9084 | 473 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.31 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.81 | gold quality |
| sperm | CL:0000019 | 80.84 | gold quality |
| left testis | UBERON:0004533 | 77.79 | gold quality |
| right testis | UBERON:0004534 | 77.24 | gold quality |
| testis | UBERON:0000473 | 76.91 | gold quality |
| muscle of leg | UBERON:0001383 | 74.57 | gold quality |
| gastrocnemius | UBERON:0001388 | 74.48 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 74.16 | gold quality |
| popliteal artery | UBERON:0002250 | 71.07 | gold quality |
| tibial artery | UBERON:0007610 | 71.07 | gold quality |
| stromal cell of endometrium | CL:0002255 | 69.81 | gold quality |
| calcaneal tendon | UBERON:0003701 | 69.50 | gold quality |
| aorta | UBERON:0000947 | 69.26 | gold quality |
| mucosa of stomach | UBERON:0001199 | 68.95 | gold quality |
| monocyte | CL:0000576 | 68.84 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 68.73 | gold quality |
| right atrium auricular region | UBERON:0006631 | 68.69 | gold quality |
| leukocyte | CL:0000738 | 68.39 | gold quality |
| islet of Langerhans | UBERON:0000006 | 67.97 | gold quality |
| left coronary artery | UBERON:0001626 | 67.54 | gold quality |
| right coronary artery | UBERON:0001625 | 67.45 | gold quality |
| cardiac atrium | UBERON:0002081 | 67.45 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 67.45 | gold quality |
| thoracic aorta | UBERON:0001515 | 67.25 | gold quality |
| ascending aorta | UBERON:0001496 | 67.14 | gold quality |
| gall bladder | UBERON:0002110 | 67.13 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 67.06 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 66.96 | gold quality |
| lower esophagus | UBERON:0013473 | 66.95 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.16 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
69 targeting ZCWPW2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-345-3P | 99.89 | 70.23 | 1421 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-202-5P | 99.78 | 67.65 | 991 |
| HSA-MIR-4517 | 99.76 | 69.19 | 1867 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-5580-3P | 99.70 | 69.41 | 2052 |
| HSA-MIR-670-5P | 99.67 | 69.94 | 1565 |
| HSA-MIR-29B-2-5P | 99.67 | 68.98 | 1726 |
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
| HSA-MIR-4470 | 99.66 | 69.35 | 1767 |
| HSA-MIR-425-5P | 99.59 | 67.67 | 900 |
Literature-anchored findings (GeneRIF, showing 1)
- PRDM9 losses in vertebrates are coupled to those of paralogs ZCWPW1 and ZCWPW2. (PMID:35217607)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zcwpw2 | ENSMUSG00000032443 |
| rattus_norvegicus | Zcwpw2 | ENSRNOG00000053820 |
Paralogs (1): ZCWPW1 (ENSG00000078487)
Protein
Protein identifiers
Zinc finger CW-type PWWP domain protein 2 — Q504Y3 (reviewed: Q504Y3)
All UniProt accessions (5): C9JFK0, H7C087, H7C0K4, H7C0L9, Q504Y3
UniProt curated annotations — full annotation on UniProt →
Function. Histone methylation reader which binds to non-methylated (H3K4me0), monomethylated (H3K4me1), dimethylated (H3K4me2) and trimethylated (H3K4me3) ‘Lys-4’ on histone H3. The order of binding preference is H3K4me3 > H3K4me2 > H3K4me1 > H3K4me0.
Domain organisation. The CW-TYPE zinc finger mediates its binding to trimethylated histone H3K4me3.
RefSeq proteins (3): NP_001035522, NP_001311098, NP_001311099 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000313 | PWWP_dom | Domain |
| IPR011124 | Znf_CW | Domain |
| IPR042778 | ZCWPW1/ZCWPW2 | Family |
Pfam: PF00855, PF07496
UniProt features (22 total): mutagenesis site 8, binding site 4, strand 2, helix 2, chain 1, domain 1, turn 1, zinc finger region 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 4Z0O | X-RAY DIFFRACTION | 1.57 |
| 4Z0R | X-RAY DIFFRACTION | 1.75 |
| 4O62 | X-RAY DIFFRACTION | 1.78 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q504Y3-F1 | 72.85 | 0.34 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 33; 38; 60; 71
Mutagenesis-validated functional residues (8):
| Position | Phenotype |
|---|---|
| 30 | significantly reduced histone h3k4me3 binding. |
| 30 | loss of histone h3k4me3 binding; when associated with f-41. |
| 30 | loss of histone h3k4me3 binding. |
| 41 | significantly reduced histone h3k4me3 binding. loss of histone h3k4me3 binding; when associated with l-30 or m-30. |
| 78 | little effect on histone h3k4me3 binding. |
| 30 | reduced histone h3k4me3 binding. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 53 (showing top):
MARTIN_NFKB_TARGETS_DN, BRUINS_UVC_RESPONSE_LATE, chr3p24, PEDRIOLI_MIR31_TARGETS_UP, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN, FOXD2_TARGET_GENES, FOXJ2_TARGET_GENES, HES4_TARGET_GENES, SALL4_TARGET_GENES, MIR153_5P, MIR4495, MIR944, MIR6885_3P, MIR9_5P
GO Biological Process (1): chromatin organization (GO:0006325)
GO Molecular Function (4): zinc ion binding (GO:0008270), histone H3K4me3 reader activity (GO:0140002), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular component organization | 1 |
| transition metal ion binding | 1 |
| histone H3 reader activity | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1237 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZCWPW2 | SPO11 | Q9Y5K1 | 474 |
| ZCWPW2 | PRDM9 | Q9NQV7 | 433 |
| ZCWPW2 | NSD2 | O96028 | 415 |
| ZCWPW2 | FBXO47 | Q5MNV8 | 381 |
| ZCWPW2 | MORC3 | Q14149 | 371 |
| ZCWPW2 | TEX15 | Q9BXT5 | 371 |
| ZCWPW2 | DHRS4L2 | Q6PKH6 | 370 |
| ZCWPW2 | ANKRD31 | Q8N7Z5 | 367 |
| ZCWPW2 | ZNF133 | P52736 | 367 |
| ZCWPW2 | MEI1 | Q5TIA1 | 358 |
| ZCWPW2 | THSD1 | Q9NS62 | 343 |
| ZCWPW2 | FMR1NB | Q8N0W7 | 339 |
| ZCWPW2 | CFAP44 | Q96MT7 | 339 |
| ZCWPW2 | RPS6KA2 | Q15349 | 314 |
| ZCWPW2 | POLR3F | Q9H1D9 | 312 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HSF2BP | ZCWPW2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PBX2 | ZCWPW2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZCWPW2 | HSF2BP | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZCWPW2 | PBX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (5): ZCWPW2 (Affinity Capture-MS), ZCWPW2 (Two-hybrid), ZCWPW2 (Two-hybrid), RBM46 (Cross-Linking-MS (XL-MS)), ZCWPW2 (Reconstituted Complex)
ESM2 similar proteins: A0A163UT06, A0A7H0DN94, A6ZTB4, A7E2Z2, B9RU15, G5EBM1, H9JDT2, O13682, O13881, O17514, O76720, O94324, P04312, P0C9F5, P0C9F6, P21012, P32097, P33071, P38890, P41474, P42124, P47156, P70351, Q08BS4, Q09291, Q10077, Q15910, Q18008, Q18317, Q28D84, Q4R381, Q4V863, Q504Y3, Q5RDS6, Q5UNX9, Q5UQB9, Q5UR71, Q61188, Q84WW6, Q8VZJ1
Diamond homologs: Q08EN7, Q504Y3, Q8TE76, Q2LAE1, Q9H0M4, E1BYJ2, O96028, P52701, P54276, Q6IR42, Q8BMD7, Q8BVE8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
77 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 64 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2088 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:28413052:CCAG:C | acceptor_loss | 1.0000 |
| 3:28413053:CAG:C | acceptor_loss | 1.0000 |
| 3:28413054:A:AG | acceptor_gain | 1.0000 |
| 3:28413054:A:C | acceptor_loss | 1.0000 |
| 3:28413055:G:GG | acceptor_gain | 1.0000 |
| 3:28413055:GAT:G | acceptor_gain | 1.0000 |
| 3:28413055:GATT:G | acceptor_gain | 1.0000 |
| 3:28413055:GATTA:G | acceptor_gain | 1.0000 |
| 3:28435104:T:TA | acceptor_gain | 1.0000 |
| 3:28435107:AAGTT:A | acceptor_gain | 1.0000 |
| 3:28435108:A:G | acceptor_gain | 1.0000 |
| 3:28435109:GTT:G | acceptor_gain | 1.0000 |
| 3:28435270:G:GA | donor_loss | 1.0000 |
| 3:28478801:T:A | acceptor_gain | 1.0000 |
| 3:28478811:T:G | acceptor_gain | 1.0000 |
| 3:28478812:A:AG | acceptor_gain | 1.0000 |
| 3:28478813:G:GA | acceptor_gain | 1.0000 |
| 3:28478813:GC:G | acceptor_gain | 1.0000 |
| 3:28478813:GCCA:G | acceptor_gain | 1.0000 |
| 3:28492172:GG:G | donor_gain | 1.0000 |
| 3:28492173:GG:G | donor_gain | 1.0000 |
| 3:28496796:A:AG | acceptor_gain | 1.0000 |
| 3:28496797:G:GG | acceptor_gain | 1.0000 |
| 3:28496900:AAAAG:A | donor_loss | 1.0000 |
| 3:28496901:AAAG:A | donor_loss | 1.0000 |
| 3:28496902:AA:A | donor_gain | 1.0000 |
| 3:28496902:AAGTA:A | donor_loss | 1.0000 |
| 3:28496903:AG:A | donor_loss | 1.0000 |
| 3:28496904:G:GG | donor_gain | 1.0000 |
| 3:28496905:T:TC | donor_loss | 1.0000 |
AlphaMissense
2365 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:28413189:T:A | W41R | 0.996 |
| 3:28413189:T:C | W41R | 0.996 |
| 3:28413194:A:C | R42S | 0.995 |
| 3:28413194:A:T | R42S | 0.995 |
| 3:28413240:T:A | W58R | 0.995 |
| 3:28413240:T:C | W58R | 0.995 |
| 3:28435111:T:A | W112R | 0.994 |
| 3:28435111:T:C | W112R | 0.994 |
| 3:28413156:T:A | W30R | 0.993 |
| 3:28413156:T:C | W30R | 0.993 |
| 3:28413191:G:C | W41C | 0.993 |
| 3:28413191:G:T | W41C | 0.993 |
| 3:28413193:G:C | R42T | 0.992 |
| 3:28435198:T:C | F141L | 0.992 |
| 3:28435200:C:A | F141L | 0.992 |
| 3:28435200:C:G | F141L | 0.992 |
| 3:28413165:T:C | C33R | 0.989 |
| 3:28413242:G:C | W58C | 0.989 |
| 3:28413242:G:T | W58C | 0.989 |
| 3:28413373:T:A | V102D | 0.989 |
| 3:28413165:T:A | C33S | 0.988 |
| 3:28413166:G:C | C33S | 0.988 |
| 3:28413246:T:C | C60R | 0.985 |
| 3:28435113:G:C | W112C | 0.985 |
| 3:28435113:G:T | W112C | 0.985 |
| 3:28413158:G:C | W30C | 0.984 |
| 3:28413158:G:T | W30C | 0.984 |
| 3:28413192:A:G | R42G | 0.983 |
| 3:28435199:T:C | F141S | 0.983 |
| 3:28435118:G:A | G114E | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000007672 (3:28376588 C>G), RS1000050273 (3:28407435 A>G,T), RS1000076633 (3:28481047 A>T), RS1000099845 (3:28411197 C>T), RS1000100240 (3:28498528 G>A), RS1000111824 (3:28393421 A>G), RS1000113836 (3:28437145 C>T), RS1000114026 (3:28371123 C>T), RS1000125709 (3:28396118 A>G), RS1000143958 (3:28455299 G>A,T), RS1000149630 (3:28454552 T>C), RS1000152788 (3:28498242 T>C), RS1000166982 (3:28483745 A>G), RS1000171590 (3:28361264 T>C), RS1000175764 (3:28455729 T>C)
Disease associations
OMIM: gene MIM:621188 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003901_9 | Cognitive decline (age-related) | 1.000000e-06 |
| GCST90002388_190 | Lymphocyte count | 6.000000e-09 |
| GCST90002399_133 | Neutrophil percentage of white cells | 3.000000e-14 |
| GCST90007005_1 | Gut microbiota relative abundance (Eubacterium belonging to family Erysipelotrichaceae) | 3.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004587 | lymphocyte count |
| EFO:0007990 | neutrophil percentage of leukocytes |
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation | 2 |
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.